Be Aware of Addyi's (Flibanserin) Risks

Women may ask you about Addyi (ADD-ee, flibanserin), the first drug for hypoactive sexual desire in PREmenopausal women.

Addyi will be out in the U.S. first...and will soon be considered for approval in Canada too.

You'll hear it dubbed "the pink Viagra"...but this is misleading.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote